These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5349820)

  • 21. [Evaluation of the efficiency of the locomotor system in children with hemophilia treated in Olsztyn Province 1981-1986].
    Makowska K; Kołtun W; Lipecki W
    Pediatr Pol; 1988 May; 63(5):291-7. PubMed ID: 3217173
    [No Abstract]   [Full Text] [Related]  

  • 22. Coagulation factor therapy for hemophilia: relation to hepatitis B and to liver function.
    Card RT; Dusevic M; Lukie BE
    Can Med Assoc J; 1982 Jan; 126(1):34-6. PubMed ID: 7059871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the management of the child who has hemophilia.
    Dunn AL; Abshire TC
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1249-76, viii. PubMed ID: 15511615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced communication between care professionals and patients with hemophilia by using a web enabled electronic logbook.
    Roosendaal G; Drenth ER; Poerschke M; Verkerk EC; Van den Berg HM; Metselaar M
    Stud Health Technol Inform; 2004; 103():191-4. PubMed ID: 15747920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orthopedic outcome studies and cost issues.
    Aledort LM
    Semin Thromb Hemost; 2003 Feb; 29(1):55-60. PubMed ID: 12640566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experiences from the Hemophilia Clinic. II].
    van Creveld S; Kingma MJ; Mochtar IA; Stibbe J
    Ned Tijdschr Geneeskd; 1968 Jul; 112(30):1372-7. PubMed ID: 5680828
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment for hemophilia: recombinant versus plasma-derived coagulation factors - controversy and debate forever? An ethical medical challenge?
    Liras A; García-Trenchard R
    Expert Rev Hematol; 2013 Oct; 6(5):489-92. PubMed ID: 24083561
    [No Abstract]   [Full Text] [Related]  

  • 28. [Oral surgery in hemophilic patients].
    Johansen J
    Nor Tannlaegeforen Tid; 1969 Oct; 79(8):535-45. PubMed ID: 5310921
    [No Abstract]   [Full Text] [Related]  

  • 29. 10th Novo Nordisk Symposium on Haemostasis Management--introduction.
    Roberts HR
    Haemophilia; 2010 May; 16 Suppl 3():1-2. PubMed ID: 20586793
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cure of hemophilia is approaching. Gene therapy is the hope].
    Schulman S
    Lakartidningen; 2001 Nov; 98(48):5454-7. PubMed ID: 11769359
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemophilia in the developing world: transforming lives through international collaboration.
    Jandial A; Mishra K; Sandal R; Jindal N; Goni D; Lad D; Prakash G; Khadwal A; Ahluwalia J; Varma N; Malhotra P
    Blood Adv; 2018 Nov; 2(Suppl 1):39-41. PubMed ID: 30504198
    [No Abstract]   [Full Text] [Related]  

  • 32. Gene therapy for hemophilia A and B: patient selection and follow-up, requirements for a cure.
    Lusher JM
    Thromb Haemost; 1999 Aug; 82(2):572-5. PubMed ID: 10605753
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current problems of hemophilia treatment].
    Eizo K
    Rinsho Ketsueki; 2002 Mar; 43(3):161-4. PubMed ID: 11979746
    [No Abstract]   [Full Text] [Related]  

  • 34. Issues surrounding therapeutic choices for hemophilia patients.
    Van den Berg HM
    Haematologica; 2004 Jun; 89(6):645-50. PubMed ID: 15194529
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of patients with bleeding disorders.
    Wyld PJ; Dawson KP
    N Z Med J; 1984 Feb; 97(750):118-9. PubMed ID: 6424072
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lymphocyte subpopulations in hemophilia A and B].
    Ollero M; Leal M; Wichman I; García M; Muñoz J; Miranda ML; Jiménez JM; Núñez A; Pascual A; Lissen E
    Med Clin (Barc); 1984 Oct; 83(12):479-81. PubMed ID: 6439957
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of hemophilia].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract]   [Full Text] [Related]  

  • 38. Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients.
    Roosendaal G; van der Schouw Y; Mauser-Bunschoten E; Borleffs J; van den Berg H
    Vox Sang; 1998; 75(4):261-6. PubMed ID: 9873260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of a wireless, handheld monitoring system in the management of hemophilia patients.
    Leone JR
    Comput Inform Nurs; 2011 Sep; 29(9):521-2. PubMed ID: 21239988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in the lymphocyte regulatory subpopulations in hemophilia patients resulting from immunocorrective therapy].
    Pliushch OP; Kopylov KG; Bulycheva TI; Novikova MN
    Ter Arkh; 1997; 69(7):40-2. PubMed ID: 9424756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.